Cargando…
Ribavirin Aerosol in the Treatment of SARS-CoV-2: A Case Series
Ribavirin is an inosine monophosphate dehydrogenase inhibitor with demonstrated activity against coronaviruses, including SARS-CoV-2. Five hospitalized patients with COVID-19 (confirmed by positive tests for SARS-CoV-2) received treatment with ribavirin for inhalation solution (ribavirin aerosol) as...
Autores principales: | Messina, Emanuela, Danise, Anna, Ferrari, Giulio, Andolina, Andrea, Chiurlo, Matteo, Razanakolona, Marie, Barakat, Maxime, Israel, Robert J., Castagna, Antonella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302211/ https://www.ncbi.nlm.nih.gov/pubmed/34302258 http://dx.doi.org/10.1007/s40121-021-00493-9 |
Ejemplares similares
-
Ribavirin aerosol in hospitalized adults with respiratory distress and COVID‐19: An open‐label trial
por: Poulakou, Garyfallia, et al.
Publicado: (2022) -
Complications of SARS-CoV-2 Infection During Cardiac Rehabilitation: A Case Series
por: Zappa, Martina, et al.
Publicado: (2023) -
Probable West Nile Virus hepatitis: Case report
por: Mori, Giovanni, et al.
Publicado: (2023) -
Calcipotriol/betamethasone dipropionate aerosol foam for the treatment of psoriasis vulgaris: case series and review of the literature
por: Pinter, Andreas, et al.
Publicado: (2018) -
Myofascial pain syndrome and SARS-CoV-2: a case series
por: Patel, Jaldhi, et al.
Publicado: (2021)